Journal of Clinical Virology

Article	Citations
Panbio antigen rapid test is reliable to diagnose SARS-CoV-2 infection in the first 7 days after the onset of symptoms	187
Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2	169
Prevalence, clinical characteristics, and outcomes of pediatric COVID-19: A systematic review and meta-analysis	119
Longitudinal follow-up of IgG anti-nucleocapsid antibodies in SARS-CoV-2 infected patients up to eight months after infection	114
Significant impact of nationwide SARS-CoV-2 lockdown measures on the circulation of other respiratory virus infections in Austria	96
Evaluation of a SARS-CoV-2 rapid antigen test: Potential to help reduce community spread?	96
Performance of the rapid high-throughput automated electrochemiluminescence immunoassay targeting total antibodies to the SARS-CoV-2 spike protein receptor binding domain in comparison to the neutrali	93
Analytical sensitivity and clinical sensitivity of the three rapid antigen detection kits for detection of SARS-CoV-2 virus	87
SARS-CoV-2 exhibits intra-host genomic plasticity and low-frequency polymorphic quasispecies	79
Longitudinal characterization of the IgM and IgG humoral response in symptomatic COVID-19 patients using the Abbott Architect	77
Evaluation of three rapid lateral flow antigen detection tests for the diagnosis of SARS-CoV-2 infection	64
Use of the variplex™ SARS-CoV-2 RT-LAMP as a rapid molecular assay to complement RT-PCR for COVID-19 diagnosis	63
Evaluation of rapid antigen detection kit from the WHO Emergency Use List for detecting SARS-CoV-2	58
SARS-CoV-2 antibodies, serum inflammatory biomarkers and clinical severity of hospitalized COVID-19 patients	57
Comparison of SARS-CoV-2 serological tests with different antigen targets	55
Pooling of SARS-CoV-2 samples to increase molecular testing throughput	53
Comparison of eight commercial, high-throughput, automated or ELISA assays detecting SARS-CoV-2 IgG or total antibody	52
A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance	51
Recommendations for the introduction of metagenomic next-generation sequencing in clinical virology, part II: bioinformatic analysis and reporting	50
Recommendations for the introduction of metagenomic high-throughput sequencing in clinical virology, part I: Wet lab procedure	50
Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis	50
Diagnostic accuracy and feasibility of patient self-testing with a SARS-CoV-2 antigen-detecting rapid test	49
Saliva specimens for detection of severe acute respiratory syndrome coronavirus 2 in Kuwait: A cross-sectional study	49
Use of dried blood spot samples for SARS-CoV-2 antibody detection using the Roche Elecsys ® high throughput immunoassay	48
Another false-positive problem for a SARS-CoV-2 antigen test in Japan	48

SARS-CoV-2 rapid antigen test: High sensitivity to detect infectious virus	47
Clinical characteristics and comparison of longitudinal qPCR results from different specimen types in a cohort of ambulatory and hospitalized patients infected with monkeypox virus.	44
Development of a point-of-care test to detect SARS-CoV-2 from saliva which combines a simple RNA extraction method with colorimetric reverse transcription loop-mediated isothermal amplification detect	44
Diagnostic performance of a SARS-CoV-2 rapid antigen test in a large, Norwegian cohort	44
Handling and accuracy of four rapid antigen tests for the diagnosis of SARS-CoV-2 compared to RT-qPCR	39
Single-step RT-PCR assay for dual genotyping of GI and GII norovirus strains	38
Clinical COVID-19 diagnostic methods: Comparison of reverse transcription loop-mediated isothermal amplification (RT-LAMP) and quantitative RT-PCR (qRT-PCR)	38
Torque teno virus loads after kidney transplantation predict allograft rejection but not viral infection	38
Benchmark of thirteen bioinformatic pipelines for metagenomic virus diagnostics using datasets from clinical samples	38
Human Calicivirus Typing tool: A web-based tool for genotyping human norovirus and sapovirus sequences	36
A comparative evaluation between the Abbott Panbio™ COVID-19 IgG/IgM rapid test device and Abbott Architect™ SARS CoV-2 IgG assay	36
Human coronaviruses: Origin, host and receptor	36
Neutralizing antibody responses following natural SARS-CoV-2 infection: Dynamics and correlation with commercial serologic tests.	36
Lack of antibodies against seasonal coronavirus OC43 nucleocapsid protein identifies patients at risk of critical COVID-19	36
Accuracy of COVID-19 rapid antigenic tests compared to RT-PCR in a student population: The StudyCov study	35
Coronavirus discovery by metagenomic sequencing: a tool for pandemic preparedness	33
Acute bronchiolitis and respiratory syncytial virus seasonal transmission during the COVID-19 pandemic in Spain: A national perspective from the pediatric Spanish Society (AEP).	33
Diagnostic performance of CerTest and Panbio antigen rapid diagnostic tests to diagnose SARS-CoV-2 infection	33
Impaired performance of SARS-CoV-2 antigen-detecting rapid diagnostic tests at elevated and low temperatures	32
Clinical performance of the GenMark Dx ePlex respiratory pathogen panels for upper and lower respiratory tract infections	31
Evaluation of two RT-PCR screening assays for identifying SARS-CoV-2 variants	31
SARS-CoV-2 infection among asymptomatic healthcare workers of the emergency department in a tertiary care facility	31
Antibody response to SARS-CoV-2 for more than one year − kinetics and persistence of detection are predominantly determined by avidity progression and test design	31
Head-to-head comparison of two rapid high-throughput automated electrochemiluminescence immunoassays targeting total antibodies to the SARS-CoV-2 nucleoprotein and spike protein receptor binding domai	31
Focusing on severe infections with the respiratory syncytial virus (RSV) in adults: Risk factors, symptomatology and clinical course compared to influenza A / B and the original SARS-CoV-2 strain	31
Development of a rapid point-of-care test that measures neutralizing antibodies to SARS-CoV-2	30
Breakthrough COVID-19 and casirivimab-imdevimab treatment during a SARS-CoV-2 B1.617.2 (Delta) surge	29
Correlation between monkeypox viral load and infectious virus in clinical specimens	29
Evaluation of an antigen-based test for hospital point-of-care diagnosis of SARS-CoV-2 infection	29
RSV reemergence in Argentina since the SARS-CoV-2 pandemic	28
Contribution of VitaPCR SARS-CoV-2 to the emergency diagnosis of COVID-19	27
Pushing beyond specifications: Evaluation of linearity and clinical performance of the cobas 6800/8800 SARS-CoV-2 RT-PCR assay for reliable quantification in blood and other materials outside recommen	27
Detection of SARS-COV N2 Gene: Very low amounts of viral RNA or false positive?	27
Implementation of an in-house real-time reverse transcription-PCR assay for the rapid detection of the SARS-CoV-2 Marseille-4 variant	27
Use of a simplified sample processing step without RNA extraction for direct SARS-CoV-2 RT-PCR detection	26
Evaluation of a fully automated high-throughput SARS-CoV-2 multiplex qPCR assay with built-in screening functionality for del-HV69/70- and N501Y variants such as B.1.1.7	26
Dynamics of IgG-avidity and antibody levels after Covid-19	25
Rapid SARS-CoV-2 variant monitoring using PCR confirmed by whole genome sequencing in a high-volume diagnostic laboratory	25
Evaluation and clinical validation of monkeypox (mpox) virus real-time PCR assays	25
Improved oral detection is a characteristic of Omicron infection and has implications for clinical sampling and tissue tropism	24
Rapid screening method for the detection of SARS-CoV-2 variants of concern	24
Comparative performance of multiplex salivary and commercially available serologic assays to detect SARS-CoV-2 IgG and neutralization titers	24
Detection of SARS-CoV-2 variants by Abbott molecular, antigen, and serological tests	24
NVX-CoV2373-induced cellular and humoral immunity towards parental SARS-CoV-2 and VOCs compared to BNT162b2 and mRNA-1273-regimens	24
Comparison of the GeneFinderTM COVID-19 Plus RealAmp Kit on the sample-to-result Platform ELITe InGenius to the national reference method: An added value of N gene target detection?	23
Plaque-neutralizing antibody to BA.2.12.1, BA.4 and BA.5 in individuals with three doses of BioNTech or CoronaVac vaccines, natural infection and breakthrough infection	23
Evaluation on testing of deep throat saliva and lower respiratory tract specimens with Xpert Xpress SARS-CoV-2 assay	23
Interactions between seasonal human coronaviruses and implications for the SARS-CoV-2 pandemic: A retrospective study in Stockholm, Sweden, 2009-2020	22
Rapid and simultaneous identification of three mutations by the Novaplex™ SARS-CoV-2 variants I assay kit	22
Extraction-free RT-LAMP to detect SARS-CoV-2 is less sensitive but highly specific compared to standard RT-PCR in 101 samples	22

Development of the RealTime SARS-CoV-2 quantitative Laboratory Developed Test and correlation with viral culture as a measure of infectivity	22
Performance evaluation of two SARS-CoV-2 IgG/IgM rapid tests (Covid-Presto and NG-Test) and one IgG automated immunoassay (Abbott)	21
Reliable quantification of plasma HDV RNA is of paramount importance for treatment monitoring: A European multicenter study	21
Redondovirus DNA in human respiratory samples	21
Immunologic response, Efficacy, and Safety of Vaccines against COVID-19 Infection in Healthy and immunosuppressed Children and Adolescents Aged 2 – 21 years old: A Systematic Review and Meta-analysis	21
Comparative evaluation of SARS-CoV-2 IgG assays in India	21
SARS-CoV-2 whole-genome sequencing using reverse complement PCR: For easy, fast and accurate outbreak and variant analysis.	21
Analysis of cycle threshold values in SARS-CoV-2-PCR in a long-term study	21
The 2019 HPV Labnet international proficiency study: Need of global Human Papillomavirus Proficiency Testing	20
Validation and implementation of an orthopoxvirus qualitative real-time PCR for the diagnosis of monkeypox in the clinical laboratory	20
Accuracy and real life performance of a novel interferon-γ release assay for the detection of SARS-CoV2 specific T cell response	20
Analytical and clinical performance of extended HPV genotyping with BD Onclarity HPV Assay in home-collected first-void urine: A diagnostic test accuracy study	19
Prospective evaluation of ID NOW COVID-19 assay used as point-of-care test in an emergency department	19
Human adenovirus species in children with acute respiratory illnesses	19
RT-PCR based SARS-CoV-2 variant screening assays require careful quality control	18
Validation of plasma Torque Teno viral load applying a CE-certified PCR for risk stratification of rejection and infection post kidney transplantation	18
Comprehensive pathogen detection for ocular infections	18
Insights into immune evasion of human metapneumovirus: novel 180- and 111-nucleotide duplications within viral G gene throughout 2014-2017 seasons in Barcelona, Spain	18
Alternative sampling specimens for the molecular detection of mpox (formerly monkeypox) virus	18
Dynamics of breast milk antibody titer in the six months following SARS-CoV-2 infection	17
Comparison of the measured values of quantitative SARS-CoV-2 spike antibody assays	17
Comparison of SARS-CoV-2 detection from combined nasopharyngeal/oropharyngeal swab samples by a laboratory-developed real-time RT-PCR test and the Roche SARS-CoV-2 assay on a cobas 8800 instrument	17
CRISPR-cas13 enzymology rapidly detects SARS-CoV-2 fragments in a clinical setting	17
Severity of influenza virus and respiratory syncytial virus coinfections in hospitalized adult patients	17
Performance characteristics of the Abbott Alinity m SARS-CoV-2 assay	17
Hand, foot, and mouth disease outbreak by Coxsackievirus A6 during COVID-19 pandemic in 2021, São Paulo, Brazil.	16
Evaluation of sixteen ELISA SARS-CoV-2 serological tests	16
Highly sensitive and specific detection of the SARS-CoV-2 Delta variant by double-mismatch allele-specific real time reverse transcription PCR	16
Resolution of viral load in mild COVID-19 patients is associated with both innate and adaptive immune responses	16
Evaluation of the clinical and analytical performance of the Seegene allplex™ SARS-CoV-2 variants I assay for the detection of variants of concern (VOC) and variants of interests (VOI)	16
SARS-CoV-2 serology: Validation of high-throughput chemiluminescent immunoassay (CLIA) platforms and a field study in British Columbia	16
Comparative performance of WANTAI ELISA for total immunoglobulin to receptor binding protein and an ELISA for IgG to spike protein in detecting SARS-CoV-2 antibodies in Kenyan populations	15
Human herpesvirus 6 and central nervous system disease in oncology patients: A retrospective case series and literature review	15
“The effectiveness of rapid antigen test-based for SARS-CoV-2 detection in nursing homes in Valencia, Spain”	15
Comparison of five Anti-SARS-CoV-2 antibody assays across three doses of BNT162b2 reveals insufficient standardization of SARS-CoV-2 serology	15
Clinical performance of four immunoassays for antibodies to SARS-CoV-2, including a prospective analysis for the diagnosis of COVID-19 in a real-life routine care setting	15
An increase in enterovirus D68 circulation and viral evolution during a period of increased influenza like illness, The Johns Hopkins Health System, USA, 2022	15
Assessing oligonucleotide designs from early lab developed PCR diagnostic tests for SARS-CoV-2 using the PCR_strainer pipeline	15
A needle in the haystack? Assessing the significance of envelope (E) gene-negative, nucleocapsid (N2) gene-positive SARS-CoV-2 detection by the Cepheid Xpert Xpress SARS-COV-2 assay	15
SARS-CoV-2 sample-to-answer nucleic acid testing in a tertiary care emergency department: evaluation and utility	15
Increasing prevalence of HPV in oropharyngeal carcinoma suggests adaptation of p16 screening in Southeast Asia	15
Cellular and humoral immune response to SARS-CoV-2 vaccination and booster dose in immunosuppressed patients: An observational cohort study	14
A qualitative RT-PCR assay for the specific identification of the SARS-CoV-2 B.1.1.529 (Omicron) Variant of Concern	14
Viral metagenomic sequencing in a cohort of international travellers returning with febrile illness	14
Clinical performance and sample freeze-thaw stability of the cobas®6800 SARS-CoV-2 assay for the detection of SARS-CoV-2 in oro-/nasopharyngeal swabs and lower respiratory specimens	14
Monitoring of Torque Teno virus DNAemia in critically ill COVID-19 patients: May it help to predict clinical outcomes?	14
Prevalence of hepatitis E virus and its association with adverse pregnancy outcomes in pregnant women in China	14
Implementation of an in-house real-time reverse transcription-PCR assay to detect the emerging SARS-CoV-2 N501Y variants	14
Improving human papillomavirus (HPV) testing in the cervical cancer elimination era: The 2021 HPV LabNet international proficiency study	14
Performance of the cobas® HBV RNA automated investigational assay for the detection and quantification of circulating HBV RNA in chronic HBV patients	14
Increasing horizontal transmission of human T-cell leukemia virus type 1 in adolescents and young adults in Japan	14
The circulation of Non-SARS-CoV-2 respiratory viruses and coinfections with SARS-CoV-2 during the surge of the Omicron variant	13
Evaluation of commercial Anti-SARS-CoV-2 neutralizing antibody assays in seropositive subjects	13
Respiratory Influenza viral load as a marker of poor prognosis in patients with severe symptoms	13
Determining the reliability of rapid SARS-CoV-2 antigen detection in fully vaccinated individuals	13
A novel multiplex electrochemiluminescent immunoassay for detection and quantification of anti-SARS-CoV-2 IgG and anti-seasonal endemic human coronavirus IgG	13
Clinical validation of a quantitative HIV-1 DNA droplet digital PCR assay: Applications for detecting occult HIV-1 infection and monitoring cell-associated HIV-1 dynamics across different subtypes in	13
Rapid and accurate identification of SARS-CoV-2 Omicron variants using droplet digital PCR (RT-ddPCR)	13
Comparison of anti-SARS-CoV-2 IgG and IgA antibody responses post complete vaccination, 7 months later and after 3rd dose of the BNT162b2 vaccine in healthy adults	12
Performance evaluation of serological assays to determine the immunoglobulin status in SARS-CoV-2 infected patients	12
Development and evaluation of an RT-qPCR for the identification of the SARS-CoV-2 Omicron variant	12
Performance of six rapid diagnostic tests for SARS-CoV-2 antigen detection and implications for practical use	12
Pooled Testing for Surveillance of SARS-CoV-2 in Asymptomatic Individuals	12
Universal Polymerase Chain Reaction Screening for Severe Acute Respiratory Syndrome Coronavirus 2 in Asymptomatic Patients Before Hospital Admission in Tokyo, Japan	12
Low prevalence of SARS-CoV-2 in plasma of COVID-19 patients presenting to the emergency department	12
Performance of saliva as a specimen to detect SARS-CoV-2	12
Titers and breadth of neutralizing antibodies against SARS-CoV-2 variants after heterologous booster vaccination in health care workers primed with two doses of ChAdOx1 nCov-19: A single-blinded, rand	12
Molecular characterisation and epidemiology of enterovirus-associated aseptic meningitis in the Western and Eastern Cape Provinces, South Africa 2018–2019	12
Real-life evaluation of the Sofia SARS-CoV-2 antigen assay in a large tertiary care hospital	12
Performance of the Diasorin SARS-CoV-2 antigen detection assay on the LIAISON XL	11
A reverse-transcription droplet digital PCR assay to detect and quantify SARS-CoV-2 RNA in upper respiratory tract specimens	11
Prediction of humoral and cellular immune response to COVID-19 mRNA vaccination by TTV load in kidney transplant recipients and hemodialysis patients	11
Head-to-head validation of six immunoassays for SARS-CoV-2 in hospitalized patients	11
Natural spring water gargle and direct RT-PCR for the diagnosis of COVID-19 (COVID-SPRING study)	11
Stability of SARS-CoV-2 IgG in multiple laboratory conditions and blood sample types	11
Clinical performance evaluation of the Fluorecare® SARS-CoV-2 & Influenza A/B & RSV rapid antigen combo test in symptomatic individuals	11
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2	11
A metagenomics workflow for SARS-CoV-2 identification, co-pathogen detection, and overall diversity	11
Evaluating the efficacy and safety of a novel prophylactic nasal spray in the prevention of SARS-CoV-2 infection: A multi-centre, double blind, placebo-controlled, randomised trial.	11
Evaluation of 16 molecular assays for the detection of orthopox and mpox viruses	11

The challenges of defining sample adequacy in an era of HPV based cervical screening	11
Effective Letermovir Prophylaxis of CMV infection post allogeneic hematopoietic cell transplantation: Results from the French temporary authorization of use compassionate program	11
Performance evaluation of the fully automated molecular system Alinity m in a high-throughput central laboratory	11
Viral culture and immunofluorescence for the detection of SARS-CoV-2 infectivity in RT-PCR positive respiratory samples	11
Severity outcomes associated with SARS-CoV-2 XBB variants, an observational analysis	11
Clinical characteristics and outcomes of measles outbreak in adults: A multicenter retrospective observational study of 93 hospitalized adults in Greece	11
Molecular point-of-care devices for the diagnosis of infectious diseases in resource-limited settings – A review of the current landscape, technical challenges, and clinical impact	11
Wave comparisons of clinical characteristics and outcomes of COVID-19 admissions - Exploring the impact of treatment and strain dynamics	10
Investigation of saliva, tongue swabs and buccal swabs as alternative specimen types to nasopharyngeal swabs for SARS-CoV-2 testing	10
A simplified, amplicon-based method for whole genome sequencing of human respiratory syncytial viruses	10
Importance of external quality assessment for SARS-CoV-2 antigen detection during the COVID-19 pandemic	10
A systematic review and meta-analysis of the accuracy of SARS-COV-2 IGM and IGG tests in individuals with COVID-19	10
Clinitest rapid COVID-19 antigen test for the diagnosis of SARS-CoV-2 infection: A multicenter evaluation study	10
Prevalence of hepatitis delta virus among chronic hepatitis B carriers in a large tertiary center in the Netherlands	10
Rapid syndromic testing for respiratory viral infections in children attending the emergency department during COVID-19 pandemic in Lille, France, 2021–2022	10
Combining predictive markers for severe COVID-19: Torquetenovirus DNA load and SARS-CoV-2 RNAemia	10
Comparative analysis between self-collected and clinician-collected samples for HPV testing in public health facilities in Zimbabwe	10
Evaluation of six commercial SARS-CoV-2 rapid antigen tests in nasopharyngeal swabs: Better knowledge for better patient management?	10
Drug resistance mutations in proviral DNA of HIV-infected patients with low level of viremia	10
Performance evaluation of the Viasure PCR assay for the diagnosis of monkeypox: A multicentre study	10
An evaluation of 4 commercial assays for the detection of SARS-CoV-2 antibodies in a predominantly mildly symptomatic low prevalence Australian population	9
Distinguishing cytomegalovirus meningoencephalitis from other viral central nervous system infections	9
Performance of a qualitative rapid chromatographic immunoassay to diagnose COVID-19 in patients in a middle-income country	9
A longitudinal study to detect hepatitis B surface and core-related antigens in chronic hepatitis B patients with hepatitis B surface antigen seroclearance using highly sensitive assays	9
Outpatient human coronavirus associated conjunctivitis in India	9
A multi-center study to determine genetic variations in the fusion gene of respiratory syncytial virus (RSV) from children <2 years of age in the U.S.	9
Emerging SARS-CoV-2 variant B.1.1.7 reduces neutralisation activity of antibodies against wild-type SARS-CoV-2	9
Comparative analysis of RSV-related hospitalisations in children and adults over a 7 year-period before, during and after the COVID-19 pandemic	9
A systematic review and meta-analysis of enzyme-linked immunosorbent spot (ELISPOT) assay for BK polyomavirus immune response monitoring after kidney transplantation	9
Evaluation of SARS-CoV-2 total antibody detection via a lateral flow nanoparticle fluorescence immunoassay	9
IPVS policy statement on HPV nucleic acid testing guidance for those utilising/considering HPV as primary precancer screening: Quality assurance and quality control issues	9
Validation of a modified CDC assay and performance comparison with the NeuMoDx™ and DiaSorin® automated assays for rapid detection of SARS-CoV-2 in respiratory specimens	9
Unusual high number of spike protein mutations for the SARS-CoV-2 strains detected in Hong Kong	9
Evaluation of a high volume antigen test for detection of SARS-CoV-2	9
Comparison of SARS-CoV-2 spike antibody quantitative titer reporting using the World Health Organization International Standard Units by four commercial assays	9
A Prospective Study of Plasma and Bronchoalveolar Lavage Fluid CMV DNA Load Quantification for the Diagnosis and Outcome of CMV Pneumonitis in Immunocompromised Hosts	9
A combined strategy to detect plasma samples reliably with high anti-SARS-CoV-2 neutralizing antibody titers in routine laboratories	8
Safe and effective pool testing for SARS-CoV-2 detection	8
Viral metagenomics reveals diverse anelloviruses in bone marrow specimens from hematologic patients	8
Differences in pediatric SARS-CoV-2 symptomology and Co-infection rates among COVID-19 Pandemic waves	8
Clinical scoring system to predict viable viral shedding in patients with COVID-19	8
Sequential SARS-CoV-2 IgG assays as confirmatory strategy to confirm equivocal results: Hospital-wide antibody screening in 3,569 staff health care workers in Paris	8
High-sensitivity SARS-CoV-2 group testing by digital PCR among symptomatic patients in hospital settings	8
Rapid differential diagnosis of SARS-CoV-2, influenza A/B and respiratory syncytial viruses: Validation of a novel RT-PCR assay	8
Performance evaluation of the Roche cobas 6800 system for quantifying cytomegalovirus DNA in plasma and urine samples	8
Adaptive immune responses to SARS-CoV-2 in recovered severe COVID-19 patients	8
Diagnostic accuracy of a rapid diagnostic test for the early detection of COVID-19	8
Factors associated with clinical outcomes in patients with Coronavirus Disease 2019 in Guangzhou, China	8
SARS-CoV-2 cycle threshold (Ct) values predict future COVID-19 cases	8
Expanding access to SARS-CoV-2 IgG and IgM serologic testing using fingerstick whole blood, plasma, and rapid lateral flow assays	8
Duration of viral infectiousness and correlation with symptoms and diagnostic testing in non-hospitalized adults during acute SARS-CoV-2 infection: A longitudinal cohort study	8
A quantitative assay for detection of SARS-CoV-2 neutralizing antibodies	8
Diagnostic performance of the SARS-CoV-2 S1RBD IgG ELISA (ImmunoDiagnostics) for the quantitative detection of SARS-CoV-2 antibodies on dried blood spots	8
Sierra SARS-CoV-2 sequence and antiviral resistance analysis program	8
Immune response of booster doses of BBIBP-CORV vaccines against the variants of concern of SARS-CoV-2	8
Positive predictive values of CMV-IgM and importance of CMV-IgG avidity testing in detecting primary infection in three different clinical settings. A French retrospective cohort study	8
Performance of a high-throughput, automated enzyme immunoassay for the detection of SARS-CoV-2 antigen, including in viral “variants of concern”: Implications for clinical use	8
Treatment for Epstein-Barr Virus-associated uveitis confirmed by polymerase chain reaction: Efficacy of Anti-Viral Agents and a literature review	8
Infectious causes of acute encephalitis syndrome hospitalizations in Central India, 2018–20	8
Changes in enterovirus epidemiology after easing of lockdown measures	8
Prevalence of Mpox (Monkeypox) in patients undergoing STI screening in northern California, April-September 2022	8
Deep sequencing analysis of clinical samples from patients with acute infectious conjunctivitis during the COVID-19 delta surge in Madurai, India	7
Plasma EBV-DNA and peripheral blood mononuclear cell EBV-DNA have disparate clinical relevance in patients with extranodal NK/T-cell lymphoma	7
Neutralizing antibody responses in vaccinated and unvaccinated individuals infected with Omicron BA.1 variant	7
Evaluation of the respiratory NeuMoDx™ Flu A-B/RSV/SARS-CoV-2 Vantage and Alinity m Resp-4-Plex assays	7
Epidemiological and genetic characteristics of respiratory syncytial virus infection in children from Hangzhou after the peak of COVID-19	7
Evaluation of the Alinity m HIV-1 assay for the quantification of HIV-1 RNA plasma viral load in a high-throughput molecular laboratory in South Africa	7
Indirect impact of rotavirus vaccination on viral causes of acute gastroenteritis in the elderly	7
Surveillance and molecular characterization of human sapovirus in patients with acute gastroenteritis in Brazil, 2010 to 2017	7
Clinical features and outcomes of neonatal COVID-19: A systematic review	7
Early detection of COVID-19 outbreaks using textual analysis of electronic medical records	7
A systematic review of the maternal and neonatal complications in hepatitis B infection	7
Confirmed circulation of SARS-CoV-2 in Irish blood donors prior to first national notification of infection	7
Clinical and laboratory profile of patients with Kyasanur forest disease: A single-centre study of 192 patients from Karnataka, India	7
Real-world Evaluation of a Sample Pooling Strategy for Large-Scale Rapid COVID-19 Testing	7
Retrospective identification of congenital cytomegalovirus infection using dried blood samples - missed opportunities and lessons	7
Increased resistance of SARS-CoV-2 Lambda variant to antibody neutralization	7
Childhood encephalitis hospitalizations associated with virus agents in medium-endemic states in India	7
SARS-CoV-2 nasopharyngeal viral load in individuals infected with BA.2, compared to Alpha, Gamma, Delta and BA.1 variants: A single-center comparative analysis	7
SARS-CoV-2 transmitters have more than three times higher viral loads than non-transmitters – Practical use of viral load for disease control	7
Correlation of initial upper respiratory tract viral burden with progression to lower tract disease in adult allogeneic hematopoietic cell transplant recipients	7
Increased circulating levels of High Mobility Group Box 1 (HMGB1) in acute-phase Chikungunya virus infection: Potential disease biomarker	7
Evaluation of the immune response to COVID-19 vaccine mRNA BNT162b2 and correlation with previous COVID-19 infection	7
Genotypic and predicted phenotypic analysis of SARS-COV-2 Omicron subvariants in immunocompromised patients with COVID-19 following tixagevimab-cilgavimab prophylaxis	7
Arbovirus outbreak in a rural region of the Brazilian Amazon	7
Importance of internal controls to monitor adequate specimen collection: The case of orthopoxvirus real-time PCR	6
Clinical features and outcomes of neonatal dengue at the Children’s Hospital 1, Ho Chi Minh, Vietnam	6
Nosocomial transmission of hepatitis E virus and development of chronic infection: The wider impact of COVID-19	6
Subclinical CMV viremia is associated with increased nosocomial infections and prolonged hospitalization in patients with systemic autoimmune diseases	6
JC polyomavirus DNA detection in clinical practice	6
Evaluating sensitivity and specificity of the Biomeme Franklin™ three9 real-time PCR device and SARS-CoV-2 go-strips assay using clinical samples	6
Field evaluation of HIV-1 viral load monitoring in adults and children receiving antiretroviral treatment in Nigeria by dried blood spot testing with RealTime HIV-1 on m2000	6
Clinical features and laboratory diagnosis of emerging arthropod-transmitted viruses	6
First performance report of QIAreach™ Anti-SARS-CoV-2 Total Test, an innovative nanoparticle fluorescence digital detection platform	6
Clinical evaluation of the molecular-based BD SARS-CoV-2/Flu for the BD MAX™ system	6